Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
IBX will no longer cover drugs like Ozempic when they are prescribed solely for weight loss
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, whether they utilize weight loss drugs or not,” IBX said in a statement.
What to Know About Ozempic, Wegovy and the New Weight-Loss Market
Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new class of weight-loss drugs.
Elon Musk admits to taking weight-loss drug while dressed as ‘Ozempic Santa’ on Christmas
The Tesla CEO told X users he is currently taking Mounjaro because it “seems to have fewer side effects and be more effective” than Ozempic.
“Looking Good, Santa”: Elon Musk Admits To Using Mounjaro For Weight Loss In “Ozempic Santa” Post
Elon Musk uses the weight-loss drug Mounjaro, he newly revealed, as he jokingly referred to himself as “Ozempic Santa” in a Santa suit. Taking to the social media platform he owns, X (formerly known as Twitter),
Elon Musk jokes about being ‘Ozempic Santa’ with trimmed-down selfie
DOGE co-chair Elon Musk shocked his followers on Christmas Day by posting a tweet of his trimmed-down self in a Santa outfit.
Elon Musk Shares Christmas Weight-Loss Post: 'Ozempic Santa'
Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of himself wearing a Santa costume. "Ozempic Santa," the Tesla and SpaceX CEO posted alongside a photo of himself in the classic red outfit and white beard.
Elon Musk's 'Ozempic Santa' post turns heads, clashes with RFK Jr.'s stance
Elon Musk turned heads with a decadent his tree. Dressed head-to-toe in a Santa costume, he captioned his photo "Ozempic Santa," flaunting a slimmer figure. Kennedy has taken a strong anti-Ozempic stance in his pledge to tackle high rates of chronic disease,
Elon Musk dubs himself "Ozempic Santa" as weight loss drugs go mainstream
Elon Musk showed off a trimmer figure in a holiday social media post on Wednesday while revealing that he has been taking an anti-obesity drug to shed pounds. Why it matters: Musk's post highlighted just how mainstream weight-loss drugs like Ozempic and Wegovy have become in recent years as public figures openly admit to using them,
A Slimmer Elon Musk Poses as ‘Ozempic Santa’ in Bizarre Snap
Billionaire Tesla CEO Elon Musk showed off a slimmer build in a Christmas day tweet in which he declared himself, “Ozempic Santa.” In the photo shared with the tweet, Musk strikes a modelesque pose in front of a Christmas tree while dressed as Santa Claus.
Elon Musk Showed Off His Slimmed-Down Physique While Dressed Up As ‘Ozempic Santa’
The world's richest man, Elon Musk, showed off his weight loss while dressed up as 'Ozempic Santa' on X (formerly known as Twitter). Musk later made sure
Elon Musk Is Unrecognizable as 'Ozempic Santa' in New Photo Flaunting Major Weight Loss
Kennedy Jr. last month, it seems Elon Musk is trying to shed a few pounds—with a little pharmaceutical assistance. The billionaire shared a photo of himself dressed up as Santa Claus in front of a Christmas tree on X this week with the caption,
The Motley Fool on MSN
2h
Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear.
Novo's Ozempic is approved by the U.S. Food and Drug Administration (FDA) to treat diabetes, while
Wegovy
is primarily ...
24/7 Wall St
2h
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Benefits Pro
4h
Medicaid spending on GLP-1s exceeded $3.5B in past year
California’s Medicaid program spent the most of all states on GLP-1 coverage, exceeding $1.4 billion, or $118 per enrollee.
4h
Down 19% in 1 Day, Is Novo Nordisk Stock Still a Buy?
Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk 's ( NVO 0.15%) stock crashed ...
dailymemphian
3d
‘It’s bonkers’ — how Ozempic, Wegovy change lives of those who struggle to lose weight
Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...
New Scientist
1d
Why US obesity rates fell for the first time in decades
After years of rising obesity rates in the US, the numbers dipped slightly during 2023, though experts disagree about the ...
4d
on MSN
Novo Nordisk stock price takes a tumble after the Wegovy maker’s next-generation weight-loss drug underwhelms
Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down ...
Opinion
2d
Opinion
We've Accepted Wegovy and Zepbound. The Next Phase Is Harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Novo Nordisk
weight loss
Food and Drug Administration
Zepbound
Feedback